Allosteric targeting of receptor tyrosine kinases

Frederik De Smet, Arthur Christopoulos, Peter Carmeliet

Research output: Contribution to journal › Article › Research › peer-review

Abstract

The drug discovery landscape has been transformed over the past decade by the discovery of allosteric modulators of all major mammalian receptor superfamilies. Allosteric ligands are a rich potential source of drugs and drug targets with clear therapeutic advantages. G protein?coupled receptors, ligand-gated ion channels and intracellular nuclear hormone receptors have all been targeted by allosteric modulators. More recently, a receptor tyrosine kinase (RTK) has been targeted by an extracellular small-molecule allosteric modulator. Allosteric mechanisms of structurally distinct molecules that target the various receptor families are more alike than originally anticipated and include selectivity, orthosteric probe dependence and pathway-biased signaling.
Original languageEnglish
Pages (from-to)1113 - 1120
Number of pages8
JournalNature Biotechnology
Volume32
Issue number11
DOIs
Publication statusPublished - 2014

Cite this

De Smet, Frederik ; Christopoulos, Arthur ; Carmeliet, Peter. / Allosteric targeting of receptor tyrosine kinases. In: Nature Biotechnology. 2014 ; Vol. 32, No. 11. pp. 1113 - 1120.
@article{4e82c40a45e04a438b634eecd37224fd,
title = "Allosteric targeting of receptor tyrosine kinases",
abstract = "The drug discovery landscape has been transformed over the past decade by the discovery of allosteric modulators of all major mammalian receptor superfamilies. Allosteric ligands are a rich potential source of drugs and drug targets with clear therapeutic advantages. G protein?coupled receptors, ligand-gated ion channels and intracellular nuclear hormone receptors have all been targeted by allosteric modulators. More recently, a receptor tyrosine kinase (RTK) has been targeted by an extracellular small-molecule allosteric modulator. Allosteric mechanisms of structurally distinct molecules that target the various receptor families are more alike than originally anticipated and include selectivity, orthosteric probe dependence and pathway-biased signaling.",
author = "{De Smet}, Frederik and Arthur Christopoulos and Peter Carmeliet",
year = "2014",
doi = "10.1038/nbt.3028",
language = "English",
volume = "32",
pages = "1113 -- 1120",
journal = "Nature Biotechnology",
issn = "1087-0156",
publisher = "Nature Publishing Group",
number = "11",

}

De Smet, F, Christopoulos, A & Carmeliet, P 2014, 'Allosteric targeting of receptor tyrosine kinases' Nature Biotechnology, vol. 32, no. 11, pp. 1113 - 1120. https://doi.org/10.1038/nbt.3028

Allosteric targeting of receptor tyrosine kinases. / De Smet, Frederik; Christopoulos, Arthur; Carmeliet, Peter.

In: Nature Biotechnology, Vol. 32, No. 11, 2014, p. 1113 - 1120.

Research output: Contribution to journal › Article › Research › peer-review

TY - JOUR

T1 - Allosteric targeting of receptor tyrosine kinases

AU - De Smet, Frederik

AU - Christopoulos, Arthur

AU - Carmeliet, Peter

PY - 2014

Y1 - 2014

N2 - The drug discovery landscape has been transformed over the past decade by the discovery of allosteric modulators of all major mammalian receptor superfamilies. Allosteric ligands are a rich potential source of drugs and drug targets with clear therapeutic advantages. G protein?coupled receptors, ligand-gated ion channels and intracellular nuclear hormone receptors have all been targeted by allosteric modulators. More recently, a receptor tyrosine kinase (RTK) has been targeted by an extracellular small-molecule allosteric modulator. Allosteric mechanisms of structurally distinct molecules that target the various receptor families are more alike than originally anticipated and include selectivity, orthosteric probe dependence and pathway-biased signaling.

AB - The drug discovery landscape has been transformed over the past decade by the discovery of allosteric modulators of all major mammalian receptor superfamilies. Allosteric ligands are a rich potential source of drugs and drug targets with clear therapeutic advantages. G protein?coupled receptors, ligand-gated ion channels and intracellular nuclear hormone receptors have all been targeted by allosteric modulators. More recently, a receptor tyrosine kinase (RTK) has been targeted by an extracellular small-molecule allosteric modulator. Allosteric mechanisms of structurally distinct molecules that target the various receptor families are more alike than originally anticipated and include selectivity, orthosteric probe dependence and pathway-biased signaling.

UR - http://www.nature.com/nbt/journal/v32/n11/pdf/nbt.3028.pdf

U2 - 10.1038/nbt.3028

DO - 10.1038/nbt.3028

M3 - Article

VL - 32

SP - 1113

EP - 1120

JO - Nature Biotechnology

JF - Nature Biotechnology

SN - 1087-0156

IS - 11

ER -

De Smet F, Christopoulos A, Carmeliet P. Allosteric targeting of receptor tyrosine kinases. Nature Biotechnology. 2014;32(11):1113 - 1120. https://doi.org/10.1038/nbt.3028

Access to Document